Emerald Raises €1.66 Mn to Expand AI-Powered Preventive Healthcare Platform

The latest funding includes an €832,200 (£700,000) grant from Innovate UK. This is the second time Emerald has received funding from the organisation.

The company also secured another €832,200 (£700,000) in venture capital investment following the grant. Both existing investors and new backers supported the round, including Sequel and Highgoal.

Following this latest funding round, Emerald's valuation has increased compared with its previous round. The company will use the additional funding to support its continued growth and development.

Alexander Badalyan, co-founder and CEO of Emerald, explained, “There’s huge demand for access to simple healthcare tools that move beyond just testing. People want to understand what those results mean and the steps they can take to boost their long-term health – informed by guidance from trusted medical experts. A preventative approach to healthcare significantly improves long-term health outcomes by providing a more holistic view of a patient’s health, highlighting potential issues before they become critical, and empowering people to enter the right pathway earlier."

Chris Sawyer, Innovation Lead, Digital Health at Innovate UK, said, “Connecting earlier health insights with appropriate care is an important opportunity for healthcare innovation in the UK. Through this award, we are supporting Emerald’s development of AI-enabled technology designed to help clinicians deliver more personalised, proactive care. We look forward to seeing the project progress and the impact it could have on health outcomes.”

Founded in 2024, Emerald combines laboratory health tests with a digital platform that brings together test results, wearable device data and medical history in one place. This helps members spot possible health risks earlier and make better decisions about their long-term health.

Unlike traditional health checks that show a person's health at a single point in time, Emerald tracks changes over time. It combines test results with lifestyle information and wearable data to identify patterns, highlight potential risks and help users understand what needs attention.

Each member is also paired with a general practitioner (GP) who can diagnose health conditions, prescribe medication and make referrals to private healthcare providers or the NHS when needed.

Emerald was founded by healthcare professionals and is registered with the Care Quality Commission (CQC). It is authorised to provide regulated services, including diagnostic testing, screening and treatment. Its platform is also registered as a UKCA Class I medical device with the Medicines and Healthcare products Regulatory Agency (MHRA).

Read Also- XRlabs Raises €7.48 Mn Seed Funding to Advance AI-Powered Surgical Intelligence